Live Chat Software
05 - 07 November, 2019 | Hilton London Olympia , London, United Kingdom
Sylwia Stachura, Clinical Protocol Manager at Bristol-Myers Squibb
Bristol-Myers Squibb Logo

Sylwia Stachura


Clinical Protocol Manager
Bristol-Myers Squibb

Check out the incredible speaker line-up to see who will be joining Sylwia.

Download The Latest Agenda

Conference Day One

Tuesday, November 5th, 0019


9:50 AM Fireside Q&A: Designing an Effective Logistics Strategy

  • Explore how you can tackle the regulatory and logistical grey areas that exist across the European Market Place, with regards to Early Access Programmes
  • Understand the importance of a local point of contact or legal representative in your targeted market
  • Define how labelling requirements can differ when supplying drugs for a clinical trial and for an Early Access Programme and the challenges associated with importation
  • Ensure you retain oversight of an outsourced programme by defining an effective logistics strategy for your vendor

11:20 AM Early Patient Access Strategy: Successful Execution of a Named Patient Program

  • Understand the necessity of viewing an Early Patient Access (EPA) Programme as part of a continuum of product development and why early access considerations should be embedded within standard procedures
  • Ensure the success of your EPA Programme by gaining insight into the development of Bristol-Myers Squibb’s clear set of Guiding Priniples around early access
  • Highlight the importance of creating a detailed EPA Programme plan for each asset, with defined ‘trigger points’ and clear ownership and governance – assuring a successful initiation and execution of a Named Patient Programme